National Comprehensive Cancer Network

|
|
|
|
For Patients

About NCCN

Myelodysplastic Syndromes Panel

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Eyal Attar, MD

None

Celgene Corporation;
Pharmion Corporation

None

None

3/31/2008

John M. Bennett, MD

None

Novartis Pharmaceuticals Corporation

None

Celgene Corporation;
Johnson & Johnson;
Pharmion Corporation;
Telik, Inc.

7/7/2009

Clara D. Bloomfield, MD

None

None

None

None

9/28/2009

Carlos M. De Castro, MD

Celgene Corporation;
Cephalon, Inc.;
Pharmion Corporation

Alexion Pharmaceuticals, Inc.;
Celgene Corporation;
Jannsen Pharmaceutica Products, LP;
Pharmion Corporation

None

None

7/7/2009

H. Joachim Deeg, MD

None

None

None

None

9/28/2009

Harry P. Erba, MD, PhD

Cephalon, Inc.;
Eli Lilly and Company;
Exelixis Inc.;
Genzyme Corporation;
Kanisa Pharmaceuticals, Inc.;
Merck & Co., Inc.;
Novartis Pharmaceuticals Corporation;
Wyeth Pharmaceuticals;
Xanthus Pharmacueuticals, Inc.

Bristol-Myers Squibb Company;
Celgene Corporation;
Cephalon, Inc.;
Genzyme Corporation;
MGI PHARMA, INC.;
Novartis Pharmaceuticals Corporation;
Pharmion Corporation

None

National Cancer Institute

11/17/2009

James M. Foran, MD

Genzyme Corporation;
Ambit BioSciences;
Astex Therapeutics;
Seattle Genetics

Celgene Corporation;
Genzyme Corporation;
Astex Therapeutics

None

None

10/28/2009

Karin Gaensler, MD

       

Pending

Lauren Gallagher, PhD

None

None

None

None

8/28/2009

Guillermo Garcia-Manero, MD

Celgene Corporation;
Merck & Co., Inc.;
Novartis Pharmaceuticals Corporation

Merck & Co., Inc.;
MGI PHARMA, INC.;
Novartis Pharmaceuticals Corporation;
Pharmion Corporation

None

None

7/28/2009

Steven D. Gore, MD

Celgene Corporation;
Johnson & Johnson

Celgene Corporation

Celgene Corporation

None

10/21/2009

Peter L. Greenberg, MD

Amgen Inc.;
Celgene Corporation;
Novartis Pharmaceuticals Corporation

Celgene Corporation;
Novartis Pharmaceuticals Corporation

None

None

10/16/2009

Kristina M Gregory, RN, MSN, OCN

None

None

None

None

8/21/2009

David Head, MD

None

None

None

None

8/19/2009

Rashmi Kumar, PhD

None

None

None

None

7/1/2009

Lori J. Maness, MD

None

None

None

None

10/28/2009

Joan S McClure, MS

None

None

None

None

9/28/2009

Michael M. Millenson, MD, FACP

None

Celgene Corporation;
GlaxoSmithKline;
MGI PHARMA, INC.;
Pharmion Corporation

None

sanofi-aventis U.S.

10/28/2009

Tariq I. Mughal, MD, FRCP

Celgene Corporation;
Novartis Pharmaceuticals Corporation

Bristol-Myers Squibb Company;
Celgene Corporation;
Novartis Pharmaceuticals Corporation

None

None

10/7/2009

Stephen D. Nimer, MD

Celgene Corporation;
MGI PHARMA, INC.

Eisai Inc.

None

None

10/3/2008

Margaret R. O'Donnell, MD

Eisai Inc.

Celgene Corporation;
Eisai Inc.;
Genzyme Corporation

None

None

11/16/2009

Hussain I. Saba, MD, PhD

None

None

None

None

7/21/2008

Paul J. Shami, MD

Genzyme Corporation

Novartis Pharmaceuticals Corporation

JSK Therapeutics Inc.

None

10/28/2009

Dorothy Shead, MS

None

None

None

None

9/29/2009

Richard M. Stone, MD

Bristol-Myers Squibb Company;
Celgene Corporation;
Novartis Pharmaceuticals Corporation

Celgene Corporation;
Eisai Inc.;
Genzyme Corporation;
ImClone Systems Incorporated;
Merck & Co., Inc.

None

None

10/28/2009

Martin S. Tallman, MD

None

Genzyme Corporation

None

None

10/28/2009

James E. Thompson, MD

None

None

None

None

11/9/2009

Peter Westervelt, MD, PhD

None

Celgene Corporation;
Novartis Pharmaceuticals Corporation

None

None

10/6/2009

 

NCCN Website Supporters